Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2018 / Jan / Case of the Month
Histology Clinical care Histology Cytology

Case of the Month

01/22/2018 1 min read

Share

A normal-appearing, six-week-old female presented with a history of volvulus on the second day of life. “Strictured” areas of bowel were noted during ostomy takedown and resected. What is the most likely diagnosis? A. Hirschsprung’s disease
B. Intestinal atresia
C. Meconium ileus
D. Meckel’s diverticulum
E. Duplication cyst Click to register your guess We will reveal the answer in next month’s issue! Do you think you have a good case of the month? Email it to edit@thepathologist.com

Answer to last issue’s Case of the Month… D. Biphasic papillary renal cell carcinoma Biphasic papillary renal cell carcinomas (BPRCC) have papillary architecture and a dual cell population, which can also be found in other kidney tumors (1). Histologically, they resemble type 1 papillary renal cell carcinoma (PRCC) with the addition of interspersed nests of large, eosinophilic, squamous-like cells. However, they tend to be more aggressive compared with classic type 1 PRCC (2). These tumors are mostly composed of papillae covered by a single layer of small cells with regular nuclei and scant cytoplasm. Interspersed are aggregates of large, eosinophilic, squamous-like cells with higher-grade nuclei, which may comprise more than half of the tumor volume (3). Nevertheless, neither intercellular bridges nor keratin pearl formation – the distinguishing features of squamous differentiation – are present; hence the designation “squamoid” in the alternative name of this tumor: biphasic squamoid alveolar renal cell carcinoma (1,2). Moreover, squamoid cells are negative on IHC for p63 and CK5/6, confirming the lack of their squamous differentiation. Consistently, large squamoid cells exhibit the phenomenon of emperipolesis (sometimes referred to as “cells eating cells”), microscopically seen as intact adjacent cells penetrating and sitting within their cytoplasm (2). This phenomenon can be seen in some hematological disorders, such as Rosai-Dorfman disease, but has not been described in other kidney tumors. The immunohistochemical profile of BPRCC mostly matches type 1 PRCC. Tumor cells are positive for cytokeratin 7, racemase, vimentin and PAX8; additionally, the squamoid component is typically positive for cyclin D1 staining. BSARCC are negative for cytokeratin 20, cytokeratin 5/6, c-Kit, p63. They stain variable for carboanhydrase IX and CD10 (2,3). Genetically, these tumors also match the PRCC profile. Gain of chromosome 7 and 17 and loss of chromosome Y were the most frequent findings in a cohort of 11 cases (2,3). Differential diagnosis of BPRCC includes:

  • Urothelial carcinoma with squamous differentiation. They are usually located more centrally and related to the urothelium of the renal pelvis and calices. Urothelial metaplasia or dysplasia or carcinoma in situ is often found. Tumors are CK20 positive.
  • Chromophobe renal cell carcinoma with sarcomatoid and squamous transformation. These tumors are c-Kit positive and vimentin negative.
Submitted by Faruk Skenderi, Department of Pathology, University of Sarajevo Clinical Center, Sarajevo, Bosnia and Herzegovina, and Ondrej Hes, Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Pilsen, Czech Republic. References
1.    F Petersson et al., “Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma”, Ann Diagn Pathol, 16, 459–469 (2012). PMID: 23036259.
2.    O Hes et al., “Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma?”, Am J Surg Pathol, 40, 664–675 (2016). PMID: 26999503.
3.    K Trpkov et al., “Biphasic papillary renal cell carcinoma is a rare and distinct morphologic variant-clinicopathologic study of 24 novel cases”, Mod Pathol, supplS2:264A (2017).

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Event Tracking and Tracing with EMR
Clinical care
Event Tracking and Tracing with EMR

January 7, 2022

1 min read

Can tracking medical events, rather than patients, help us tackle diagnostic error?

2021: A Laboratory Medicine Roundup
Clinical care
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

Not Just a Sample
Clinical care
Not Just a Sample

January 27, 2022

13 min read

Patient–pathologist interactions are vital – and both sides must work together to make the connection

Video: Not Just a Sample
Clinical care
Video: Not Just a Sample

January 28, 2022

1 min read

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.